---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-088948"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2023-04-03T23:59:59+00:00"
generated_at: "2026-06-17T06:47:23.097892+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics amends SVB loan agreement; raises cash collateral requirement eases account covenant

## Summary
- Third Amendment to Loan & Security Agreement, effective March 30, 2023.
- Cash collateral requirement increased to full outstanding principal plus 5.75% Final Payment, from previous half sum.
- Cash collateral will be reduced proportionally with each scheduled monthly principal and interest payment.
- Operating accounts covenant relaxed: only one account required at SVB instead of all accounts.

## SEC filing metadata
- accession: 0001193125-23-088948
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2023-04-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312523088948/0001193125-23-088948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312523088948/d491593d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-088948
- JSON: https://secwatch.observer/filing/0001193125-23-088948.json
- Plain text: https://secwatch.observer/filing/0001193125-23-088948.txt

## Key facts
- Material Agreements
  Alaunos Therapeutics, Inc. amended Third Amendment with lenders party thereto and Silicon Valley Bank (SVB), a division of First-Citizens Bank & Trust Company (effective 2023-03-30).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: lenders party thereto and Silicon Valley Bank (SVB), a division of First-Citizens Bank & Trust Company
  - Effective: 2023-03-30
  source text: Third Amendment to the Loan and Security Agreement Effective March 30, 2023, Alaunos Therapeutics, Inc. (the “Company”), as borrower, entered into a Third Amendment (the “Amendment”) to the Loan and Security Agreement, dated August 6, 2021, as previously amended (the “Original Agreement” and, as amended by the Amendment, the “Amended Agreement”), by and among the Company, the lenders party thereto and Silicon Valley Bank (“SVB”), a division of First-Citizens Bank & Trust Company (successor by purchase to the Federal Deposit Insurance Corporation as Receiver for Silicon Valley Bridge Bank, N.A. (as successor to SVB)), as administrative agent and collateral agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312523088948/0001193125-23-088948-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.